Covered recipient · General Payments record
DAVID C DEIBERT
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2023
$3,933.71
- Reported across 290 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.86 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $62.37 | 3 |
| ABBVIE INC. | $46.71 | 2 |
| Medtronic, Inc. | $40.08 | 2 |
| Lilly USA, LLC | $34.48 | 2 |
| Corcept Therapeutics | $26.33 | 1 |
| Merck Sharp & Dohme Corporation | $17.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.10 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018855083 | CMS |
| Abbott Laboratories | $19.84 | 06/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018882819 | CMS |
| Abbott Laboratories | $18.43 | 07/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018894839 | CMS |
| AbbVie Inc. | $29.31 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996628575 | CMS |
| AbbVie Inc. | $17.40 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996628579 | CMS |
| Corcept Therapeutics | $26.33 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050839533 | CMS |
| Lilly USA, LLC | $16.97 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031352541 | CMS |
| Lilly USA, LLC | $17.51 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031435663 | CMS |
| Medtronic, Inc. | $22.25 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025881163 | CMS |
| Medtronic, Inc. | $17.83 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025881171 | CMS |
| Merck Sharp & Dohme LLC | $17.89 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048674441 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.